TapewireFind a company

person · Reporting owner

Naini Nader J

Disclosed activity across 2 companies

Tapewire entity
166689
SEC CIK
0001344203

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Sierra Oncology, Inc.SRRA · Entity 12569810% ownerFebruary 14, 2017February 24, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect2,186,195 Reported balance Holding disclosure · report date 2017-02-14 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,186,195

F1: Represents shares held by Frazier Healthcare VI, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Common StockSEC Table I · non-derivativeDirect5,925,926 Reported balance Holding disclosure · report date 2017-02-14 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 5,925,926

F2: Represents shares held by Frazier Life Sciences VIII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares held by Frazier Healthcare VI, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F2: Represents shares held by Frazier Life Sciences VIII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Section 16 reporting ended · disclosed 2018-05-15. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnote973,612 Reported balance After 2018-05-11 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2018-05-11 · Other · Disposed 1,372,000 · Balance 973,612

F1: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 11, 2018 Filed May 15, 2018 18:25 UTC ANAPTYSBIO, INC ANAB · Entity 4640 OtherCommon Stock 1,372,000 $0.00 $0.00
Disclosure

SEC source: 0001012975-18-000437 · edgar.xml · nonDerivative · entry 1

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 973,612

F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F1 · ownership.nature: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
May 11, 2018 Filed May 15, 2018 18:25 UTC ANAPTYSBIO, INC ANAB · Entity 4640 OtherCommon Stock 1,372,000 $0.00 $0.00
Disclosure

SEC source: 0001012975-18-000436 · edgar.xml · nonDerivative · entry 1

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 973,612

F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F1 · ownership.direct: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
February 02, 2017 Filed Feb 6, 2017 17:14 UTC ANAPTYSBIO, INC ANAB · Entity 4640 OtherWarrants · Derivative 117,235 $0.00 Strike: $4.55 $0.00
Disclosure

SEC source: 0001012975-17-000092 · edgar.xml · derivative · entry 2

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 117,235 shares

Expires 2018-11-04

F1 · derivative.exercise_date: This warrant is exercisable at any time.

F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
February 02, 2017 Filed Feb 6, 2017 17:14 UTC ANAPTYSBIO, INC ANAB · Entity 4640 OtherCommon Stock 117,235 $4.55 $533,419.25
Disclosure

SEC source: 0001012975-17-000092 · edgar.xml · nonDerivative · entry 1

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,345,612

F2 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
February 02, 2017 Filed Feb 6, 2017 17:14 UTC ANAPTYSBIO, INC ANAB · Entity 4640 OtherWarrants · Derivative 117,235 $0.00 Strike: $4.55 $0.00
Disclosure

SEC source: 0001012975-17-000091 · edgar.xml · derivative · entry 2

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 117,235 shares

Expires 2018-11-04

F1 · derivative.exercise_date: This warrant is exercisable at any time.

F2 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
February 02, 2017 Filed Feb 6, 2017 17:14 UTC ANAPTYSBIO, INC ANAB · Entity 4640 OtherCommon Stock 117,235 $4.55 $533,419.25
Disclosure

SEC source: 0001012975-17-000091 · edgar.xml · nonDerivative · entry 1

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,345,612

F2 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries D Preferred Stock · Derivative 209,095 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 12

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 209,095 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F7 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries D Preferred Stock · Derivative 733,740 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 11

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 733,740 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F6 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries C-1 Preferred Stock · Derivative 195,751 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 10

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 195,751 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F3 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F3 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries C Preferred Stock · Derivative 604,055 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 9

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 604,055 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F2 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F2 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries B Preferred Stock · Derivative 1,428,571 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · derivative · entry 8

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,428,571 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F1 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F1 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 PurchaseCommon Stock 88,709 $15.00 $1,330,635.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 7

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 88,709

F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 PurchaseCommon Stock 311,291 $15.00 $4,669,365.00
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 6

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,291

F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 209,095 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 5

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 209,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 733,740 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 4

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 733,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F6 · ownership.direct: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 195,751 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 3

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 195,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F3 · price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 604,055 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 2

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 604,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F2 · price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:20 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 1,428,571 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000071 · edgar.xml · nonDerivative · entry 1

Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner

Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner

FHM VII, L.P. · CIK 0001654632 · 10% owner

FHM VII, L.L.C. · CIK 0001654631 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,428,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F1 · price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · ownership.nature: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries D Preferred Stock · Derivative 209,095 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 12

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 209,095 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F7 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries D Preferred Stock · Derivative 733,740 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 11

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 733,740 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.exercise_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F4 · derivative.expiration_date: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F6 · derivative.underlying_shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries C-1 Preferred Stock · Derivative 195,751 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 10

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 195,751 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F3 · derivative.exercise_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F3 · derivative.expiration_date: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries C Preferred Stock · Derivative 604,055 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 9

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 604,055 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F2 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F2 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionSeries B Preferred Stock · Derivative 1,428,571 $0.00 $0.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · derivative · entry 8

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,428,571 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F1 · derivative.exercise_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F1 · derivative.expiration_date: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · derivative.underlying_shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 PurchaseCommon Stock 88,709 $15.00 $1,330,635.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 7

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 88,709

F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 PurchaseCommon Stock 311,291 $15.00 $4,669,365.00
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 6

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 311,291

F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 209,095 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 5

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 209,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F7 · ownership.nature: Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 733,740 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 4

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 733,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · shares: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F4 · price: The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F6 · ownership.nature: Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 195,751 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 3

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F3 · price: The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 604,055 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 2

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 604,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F2 · price: The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document
January 31, 2017 Filed Jan 31, 2017 16:16 UTC ANAPTYSBIO, INC ANAB · Entity 4640 ConversionCommon Stock 1,428,571 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-17-000069 · edgar.xml · nonDerivative · entry 1

Frazier Healthcare V, LP · CIK 0001341169 · 10% owner

FHM V, LP · CIK 0001346948 · 10% owner

FHM V, LLC · CIK 0001346944 · 10% owner

FRAZIER ALAN D · CIK 0001018534 · 10% owner

Naini Nader J · CIK 0001344203 · 10% owner

Every Nathan R · CIK 0001531105 · 10% owner

Heron Patrick J · CIK 0001365617 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

F1 · price: The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations. The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date.

F5 · ownership.direct: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.